Induction of ventricular arrhythmia by high and low osmolarity ionic and nonionic contrast media.
Studies that used prolonged contrast media infusion in canine arteries have generated controversy regarding the arrhythmogenic potential of low osmolarity, nonionic contrast agents. In order to establish the relative safety of these agents in the more typical setting of bolus injections, 4 ml intracoronary bolus injections of Hypaque-76 (n = 54), Iohexol-350 (n = 51), and Iohexol-140 (n = 51) were given in random order to 10 anesthetized, open-chest dogs undergoing programmed cardiac stimulation. Hemodynamics and electrocardiogram were monitored during stimulation, both during and for 2 minutes after the end of contrast infusion. Occurrence of evoked single and coupled premature ventricular contractions and nonsustained ventricular tachycardia did not differ statistically among agents. Sustained ventricular tachycardia (five episodes) and ventricular fibrillation (seven episodes) occurred only after Hypaque-76 injections (p less than 0.002). These results differ from those in studies that use continuous contrast infusion and suggest that low osmolarity nonionic contrast agents are as safe as high osmolarity nonionic contrast media. Both appear safer than ionic contrast material.
Pinto
I M
IM
Department of Internal Medicine, Veterans Administration Medical Center, Ann Arbor, MI 48105.
Kou
W H
WH
McGillem
M J
MJ
DeBoe
S F
SF
Mickelson
J K
JK
Mancini
G B
GB
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000503:physiopathology; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D003973:Diatrizoate / Q000633:toxicity*; D004285:Dogs; D004562:Electrocardiography; D007472:Iohexol / Q000633:toxicity*; D009994:Osmolar Concentration; D013610:Tachycardia / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000139:chemically induced
D003973:Diatrizoate; D007472:Iohexol